Ingredion INGR tumbled 9.47 percent to $62.88. Ingredion's Q2 2013 EPS estimate dropped to $1.15 versus $1.33 in Q2 2012.
MiMedx Group MDXG dropped 8.54 percent to $5.78. Traders in MiMedx responded negatively to an article on SeekingAlpha.
The Female Health Company FHCO traded down 6.93 percent to $9.26 on lower shipments expectations in Q3 year over year, and also lowered guidance in sales operation income.
Dex Media DXM lowered 6.44 percent to $1.15.
Ceres CERE dropped 6.20 percent to $2.19 after Piper Jaffray downgraded the company following sweet sorghum commercial ramp delay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.